Trial Profile
Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1-infected Individuals
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 24 Nov 2021
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 03 Jun 2021 Status changed from active, no longer recruiting to completed.
- 17 Jul 2020 Planned End Date changed from 1 Sep 2020 to 1 Dec 2022.
- 17 Jul 2020 Planned primary completion date changed from 1 Jul 2020 to 1 Dec 2021.